Ignite Creation Date:
2025-12-24 @ 2:14 PM
Ignite Modification Date:
2026-01-04 @ 11:07 PM
Study NCT ID:
NCT02487095
Status:
COMPLETED
Last Update Posted:
2025-04-13
First Post:
2015-06-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-07-30
Start Date Type:
ACTUAL
Primary Completion Date:
2021-02-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-26
Completion Date Type:
ACTUAL
First Submit Date:
2015-06-27
First Submit QC Date:
None
Study First Post Date:
2015-07-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-01-25
Results First Submit QC Date:
None
Results First Post Date:
2022-04-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-24
Last Update Post Date:
2025-04-13
Last Update Post Date Type:
ACTUAL